IG, S., FE, A., JM, F., OH, I., K, A., JA, C., . . . C, A. (2026). Evaluating the impact of Lutetium-177 therapy on bioprosthetic heart valves in carcinoid heart disease. Cardio-oncology (London, England), 12(1), . https://doi.org/10.1186/s40959-026-00496-w
Chicago Style (17th ed.) CitationIG, Scalia, et al. "Evaluating the Impact of Lutetium-177 Therapy on Bioprosthetic Heart Valves in Carcinoid Heart Disease." Cardio-oncology (London, England) 12, no. 1 (2026). https://doi.org/10.1186/s40959-026-00496-w.
MLA (9th ed.) CitationIG, Scalia, et al. "Evaluating the Impact of Lutetium-177 Therapy on Bioprosthetic Heart Valves in Carcinoid Heart Disease." Cardio-oncology (London, England), vol. 12, no. 1, 2026, https://doi.org/10.1186/s40959-026-00496-w.